NCT04699942View on ClinicalTrials.gov

Pilot Study to Evaluate the Revoxa™ System in Hypoxic Patients

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

May 1, 2021

Study Completion Date

May 1, 2021

Conditions
Hypoxemia
Interventions
DEVICE

Conventional (low flow) oxygen delivery via nasal cannula

Conventional (low flow) oxygen delivery via nasal cannula or face mask for 20 minutes

DEVICE

Revoxa Oxygen Rebrearther

Oxygen delivery via Revoxa Oxygen Rebreather device for 20 minutes

Trial Locations (1)

K7L 2V7

Kingston Health Sciences Centre, Kingston

All Listed Sponsors
collaborator

Ironstone Professional Development

UNKNOWN

lead

Dr. David Maslove

OTHER

NCT04699942 - Pilot Study to Evaluate the Revoxa™ System in Hypoxic Patients | Biotech Hunter | Biotech Hunter